Movement Alert｜Aehr Test Falls 10.03% in Regular Trading, Teradyne Titan HP Competition Concerns Pressure Shares

Market Focus10-15

On October 15, Aehr Test fell 10.03% in Regular Trading, trading at $63.02/share, with turnover of $47.0395 million.

The move was tied to continued market repricing after Teradyne introduced Titan HP, which heightened competitive concerns around Aehr Test and triggered additional selling pressure as the stock extended its recent pullback.

Recent company updates, however, indicate demand has not disappeared. Over the past two months, Aehr Test disclosed a $22 million follow-on production order from a lead wafer-level AI processor customer, about $6 million in follow-on orders for AI chip testing equipment, and ongoing silicon photonics expansion orders. A recent analyst note said the post-Titan HP selloff appears overdone and characterized the weakness as a potential buying opportunity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment